FOLFOX plus nivolumab combination therapy for cisplatin-unfit patients with untreated advanced esophageal squamous cell carcinoma
{{output}}
Background: Combination chemotherapy with cisplatin and fluorouracil plus an immune checkpoint inhibitor (ICI) is a standard first-line treatment for advanced esophageal squamous cell carcinoma (ESCC). However, cisplatin is unsui... ...
